PMID: 15356146Sep 10, 2004Paper

The binding sites for competitive antagonistic, allosteric antagonistic, and agonistic antibodies to the I domain of integrin LFA-1

The Journal of Immunology : Official Journal of the American Association of Immunologists
Chafen LuT A Springer

Abstract

We explore the binding sites for mAbs to the alpha I domain of the integrin alphaLbeta2 that can competitively inhibit, allosterically inhibit, or activate binding to the ligand ICAM-1. Ten mAbs, some of them clinically important, were mapped to species-specific residues. The results are interpreted with independent structures of the alphaL I domain determined in seven different crystal lattices and in solution, and which are present in three conformational states that differ in affinity for ligand. Six mAbs bind to adjacent regions of the beta1-alpha1 and alpha3-alpha4 loops, which show only small (mean, 0.8 angstroms; maximum, 1.8 angstroms) displacements among the eight I domain structures. Proximity to the ligand binding site and to noncontacting portions of the ICAM-1 molecule explains competitive inhibition by these mAbs. Three mAbs bind to a segment of seven residues in the beta5-alpha6 loop and alpha6 helix, in similar proximity to the ligand binding site, but on the side opposite from the beta1-alpha1/alpha3-alpha4 epitopes, and far from noncontacting portions of ICAM-1. These residues show large displacements among the eight structures in response to lattice contacts (mean, 3.6 angstroms; maximum, 9.4 angstroms), and ...Continue Reading

References

Apr 1, 1990·Immunological Reviews·R S Larson, T A Springer
Mar 1, 1983·European Journal of Immunology·J E HildrethA J McMichael
Dec 1, 1982·Proceedings of the National Academy of Sciences of the United States of America·F Sanchez-MadridT A Springer
Nov 1, 1981·The Journal of Experimental Medicine·I S Trowbridge, M B Omary
Oct 24, 1995·Proceedings of the National Academy of Sciences of the United States of America·A Qu, D J Leahy
Mar 1, 1993·The Journal of Cell Biology·R C LandisN Hogg
Apr 1, 1997·Proceedings of the National Academy of Sciences of the United States of America·C Huang, T A Springer
Apr 15, 1997·European Journal of Biochemistry·C G GahmbergP Kotovuori
Apr 1, 1997·Journal of Molecular Graphics & Modelling·R M Esnouf
Feb 2, 1999·Journal of Molecular Biology·L Lo ConteJ Janin
Mar 3, 1999·Proceedings of the National Academy of Sciences of the United States of America·C OxvigT A Springer
Sep 24, 1999·Journal of Molecular Biology·J KallenU Hommel
May 11, 2000·Proceedings of the National Academy of Sciences of the United States of America·J R HuthD E Staunton
Feb 28, 2001·Proceedings of the National Academy of Sciences of the United States of America·C LuT A Springer
Apr 21, 2001·The Journal of Immunology : Official Journal of the American Association of Immunologists·C LuT A Springer
May 17, 2001·Proceedings of the National Academy of Sciences of the United States of America·M ShimaokaT A Springer
May 4, 2002·Annual Review of Biophysics and Biomolecular Structure·Motomu ShimaokaTimothy A Springer
May 17, 2002·Current Biology : CB·José Luis AlonsoM Amin Arnaout
Oct 2, 2003·Current Opinion in Cell Biology·Christopher V Carman, Timothy A Springer
Dec 18, 2003·JAMA : the Journal of the American Medical Association·Kenneth B GordonUNKNOWN Efalizumab Study Group
Feb 26, 2004·Proceedings of the National Academy of Sciences of the United States of America·Wei YangTimothy A Springer
Nov 1, 1994·Acta Crystallographica. Section D, Biological Crystallography·E A Merritt, M E Murphy

❮ Previous
Next ❯

Citations

Oct 7, 2006·The Journal of Biological Chemistry·Wei YangTimothy A Springer
Aug 23, 2006·Chemical Biology & Drug Design·Meagan E AndersonTeruna J Siahaan
Mar 20, 2009·The Journal of Biological Chemistry·Yang WangQing Ma
Feb 25, 2005·Proceedings of the National Academy of Sciences of the United States of America·Gang SongJia-Huai Wang
Jan 18, 2008·The Journal of Biological Chemistry·Roberto CarreñoGlen B Legge
Mar 5, 2009·Proceedings of the National Academy of Sciences of the United States of America·Sheng LiJianping Ding
Nov 13, 2012·The Journal of Immunology : Official Journal of the American Association of Immunologists·Neha DixitScott I Simon
Jan 28, 2020·British Journal of Pharmacology·Riccardo V MancusoGabriele Weitz-Schmidt
Mar 16, 2007·Proceedings of the National Academy of Sciences of the United States of America·Dan PeerMotomu Shimaoka
Oct 4, 2011·The Journal of Biological Chemistry·Gabriele Weitz-SchmidtTimothy A Springer
Sep 29, 2011·The EMBO Journal·Thomas Schürpf, Timothy A Springer
Mar 10, 2011·Anesthesia and Analgesia·Koichi YukiMotomu Shimaoka
Dec 18, 2007·Journal of Immunoassay & Immunochemistry·Chanchal SadhuDonald E Staunton
May 25, 2013·The Journal of Biological Chemistry·Peter VandersliceRichard A F Dixon
Aug 24, 2017·Cancers·Sabine Raab-WestphalSimon L Goodman
Oct 7, 2009·Proceedings of the National Academy of Sciences of the United States of America·Hongmin ZhangJia-Huai Wang
Apr 6, 2006·Proceedings of the National Academy of Sciences of the United States of America·Moonsoo JinTimothy A Springer
Jan 17, 2014·The Journal of Immunology : Official Journal of the American Association of Immunologists·Sebastian B RieseKonrad Buscher
Jun 16, 2018·Nature Reviews. Drug Discovery·Patrick A MayesAxel Hoos
Jul 12, 2005·Molecular and Cellular Neurosciences·Vicki Waetzig, Thomas Herdegen
May 8, 2019·Molecular Pharmaceutics·Keith Henry MossMaria Taskova

❮ Previous
Next ❯

Related Concepts

Related Feeds

Adhesion Molecules in Health and Disease

Cell adhesion molecules are a subset of cell adhesion proteins located on the cell surface involved in binding with other cells or with the extracellular matrix in the process called cell adhesion. In essence, cell adhesion molecules help cells stick to each other and to their surroundings. Cell adhesion is a crucial component in maintaining tissue structure and function. Discover the latest research on adhesion molecule and their role in health and disease here.